Date: 2017-06-27
Type of information: Restructuring
Compound:
Company: Lion Biotechnologies (USA - CA), now Iovance Biotherapeutics (USA - CA)
Therapeutic area: Cancer - Oncology
Type agreement:
Action mechanism:
Disease:
Details:
- • On June 27, 2017, Iovance Biotherapeutics announced that it changed its corporate name from Lion Biotechnologies to Iovance Biotherapeutics. The company’s new NASDAQ ticker symbol “IOVA” will be effective at the open of the market on June 28, 2017. The former ticker symbol “LBIO” will remain effective through the market close today, June 27, 2017.
- As the company prepares to expand its clinical trials into Europe, with a planned submission to European health authorities in the second half of 2017, this name change allows the company the opportunity to develop a strong and unique global brand that reflects the recent advancements in evaluating TIL therapy in new indications.
Financial terms:
Latest news:
Is general: Yes
